Anthropic is launching its own drug development program for neglected diseases that the pharmaceutical industry considers unprofitable. Novartis CEO Vas Narasimhan thinks AI could cut development time from twelve years to seven or eight and double the success rate from 8 to 16 percent.
The article Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable appeared first on The Decoder.
source & further reading
the-decoder.com — original article
Mistral's open-source Leanstral 1.5 aces formal math benchmarks and catches real bugs in code
Microsoft follows Anthropic and OpenAI into the AI super app race with overhauled Copilot and AutoPilot agents
Claude Code's complicated China problem involves bans on both sides of the Pacific